open access

Vol 14, No 4 (2007)
Review articles
Published online: 2007-06-11
Get Citation

The prognostic value of stress tests in chronic heart failure

Wiktor Piechota, Grzegorz Gielerak
Cardiol J 2007;14(4):340-346.

open access

Vol 14, No 4 (2007)
Review articles
Published online: 2007-06-11

Abstract

Chronic heart failure is a debilitating condition with a poor prognosis despite advances in medical and invasive treatment modalities. Attempts have been made to improve risk stratification in order to single out very-high-risk patients who could benefit from invasive and costly therapies. Unfortunately clinical, echocardiographic, radiological or biochemical measurements performed at rest provide significant diagnostic information but fail to stratify the risk sufficiently. Cardiopulmonary exercise testing alone or in combination with stress echocardiography and biomarkers may offer a more profound insight into the progress of the disease and patient prognosis and aid in the choice of the most appropriate therapy. Peak oxygen consumption (pVO2) is the most powerful prognostic parameter obtained during cardiopulmonary exercise testing. Ventilation slopes, especially the slope of ventilation to CO2 production (VE/VCO2), can have additional prognostic value or be used as a surrogate risk predictor where exercise is sub-maximal. Other cardiopulmonary parameters seem to have, at best, an auxiliary role in risk assessment. In patients with grey zone pVO2 values the presence of contractile reserve on stress or dobutamine echocardiography can be prognostically favourable. Other echocardiographic findings, such as functional mitral regurgitation, pulmonary hypertension and right ventricle dysfunction, also yield prognostic information. Combining biomarker measurements with pVO2 obtained during the cardiopulmonary exercise test may further improve risk assessment in heart failure patients. Two markers, B type natriuretic peptides and high sensitivity C-reactive protein (hsCRP), both with established prognostic value in heart failure and cardiovascular diseases in general, are the best candidates for combined assessment with cardiopulmonary test results. Further studies are needed to confirm this notion. (Cardiol J 2007; 14: 340-346)

Abstract

Chronic heart failure is a debilitating condition with a poor prognosis despite advances in medical and invasive treatment modalities. Attempts have been made to improve risk stratification in order to single out very-high-risk patients who could benefit from invasive and costly therapies. Unfortunately clinical, echocardiographic, radiological or biochemical measurements performed at rest provide significant diagnostic information but fail to stratify the risk sufficiently. Cardiopulmonary exercise testing alone or in combination with stress echocardiography and biomarkers may offer a more profound insight into the progress of the disease and patient prognosis and aid in the choice of the most appropriate therapy. Peak oxygen consumption (pVO2) is the most powerful prognostic parameter obtained during cardiopulmonary exercise testing. Ventilation slopes, especially the slope of ventilation to CO2 production (VE/VCO2), can have additional prognostic value or be used as a surrogate risk predictor where exercise is sub-maximal. Other cardiopulmonary parameters seem to have, at best, an auxiliary role in risk assessment. In patients with grey zone pVO2 values the presence of contractile reserve on stress or dobutamine echocardiography can be prognostically favourable. Other echocardiographic findings, such as functional mitral regurgitation, pulmonary hypertension and right ventricle dysfunction, also yield prognostic information. Combining biomarker measurements with pVO2 obtained during the cardiopulmonary exercise test may further improve risk assessment in heart failure patients. Two markers, B type natriuretic peptides and high sensitivity C-reactive protein (hsCRP), both with established prognostic value in heart failure and cardiovascular diseases in general, are the best candidates for combined assessment with cardiopulmonary test results. Further studies are needed to confirm this notion. (Cardiol J 2007; 14: 340-346)
Get Citation

Keywords

heart failure; prognosis; cardiopulmonary exercise testing; stress echocardiography; biomarkers

About this article
Title

The prognostic value of stress tests in chronic heart failure

Journal

Cardiology Journal

Issue

Vol 14, No 4 (2007)

Pages

340-346

Published online

2007-06-11

Bibliographic record

Cardiol J 2007;14(4):340-346.

Keywords

heart failure
prognosis
cardiopulmonary exercise testing
stress echocardiography
biomarkers

Authors

Wiktor Piechota
Grzegorz Gielerak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl